Insmed Inc Earnings

The next earnings date for Insmed Inc is October 29, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Insmed Inc Earnings

Report DateEstimated Earnings Per Share
10/29/2025$-1.32

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Insmed Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/07/2025---$-1.70-30.77%
05/07/2025Before Market$-1.42-18.33%
02/20/2025Before Market$-1.32-7.32%
10/31/2024Before Market$-1.27-4.10%
08/08/2024Before Market$-1.94-52.76%
05/09/2024Before Market$-1.0613.82%
02/22/2024Before Market$-1.28-11.30%
10/26/2023Before Market$-1.111.77%
08/03/2023Before Market$-1.78-57.52%
05/04/2023Before Market$-1.17-5.41%
02/23/2023Before Market$-1.21-16.35%
10/27/2022Before Market$-1.09-22.47%
08/04/2022Before Market$-0.8010.11%
05/05/2022Before Market$-0.809.09%
02/17/2022Before Market$-0.95-5.56%
10/28/2021Before Market$-0.89-3.49%
08/05/2021Before Market$-0.91-7.06%
05/06/2021Before Market$-0.890.00%
02/25/2021Before Market$-1-42.86%
10/29/2020Before Market$-0.63-3.28%
08/06/2020Before Market$-0.64-1.59%
04/30/2020Before Market$-0.74-4.23%
02/25/2020Before Market$-0.59-1.72%
10/30/2019Before Market$-0.68-1.49%
08/01/2019Before Market$-0.815.81%
05/07/2019Before Market$-0.96-1.05%
02/22/2019Before Market$-1.19-13.33%
10/30/2018Before Market$-1.14-7.55%
08/02/2018Before Market$-17.41%
05/02/2018Before Market$-0.899.18%
02/23/2018Before Market$-0.85-32.81%
11/02/2017Before Market$-0.690.00%
08/03/2017Before Market$-0.72-14.29%
05/03/2017Before Market$-0.600.00%
02/23/2017Before Market$-1.10-23.60%
11/03/2016Before Market$-0.61-3.39%
08/04/2016Before Market$-0.59-5.36%
05/05/2016Before Market$-0.543.57%
02/25/2016Before Market$-0.51-4.08%
11/06/2015Before Market$-0.50-6.38%
08/06/2015Before Market$-0.472.08%
05/07/2015Before Market$-0.55-10.00%
02/27/2015Before Market$-0.3635.71%
11/06/2014Before Market$-0.54-17.39%
08/06/2014---$-0.59-28.26%
05/08/2014---$-0.3612.20%
03/06/2014---$-0.418.89%
11/05/2013---$-0.46-12.20%
08/06/2013---$-0.2812.50%
05/07/2013---$-0.436.52%
03/18/2013---$-0.49-53.13%
11/07/2012---$-0.389.52%
08/07/2012---$-0.39-18.18%
05/08/2012---$-0.2826.32%
03/13/2012---$-0.3021.05%
11/08/2011---$-0.34-21.43%
08/08/2011---$-0.40-21.21%
05/11/2011---$-0.85-165.63%
03/10/2011---$-0.42-320.00%
11/03/2010---$-0.03---
08/04/2010---$-0.03---
05/06/2010---$0.01---
03/15/2010---$0.18---
11/06/2009---$-0.01---
08/13/2009---$-0.13---
05/13/2009---$9.60---
03/11/2009---$-0.32---
10/30/2008---$-0.18---
08/08/2008---$-0.38---
05/08/2008---$-0.40---
03/04/2008---$-0.300.00%
11/08/2007---$-0.3025.00%
08/02/2007---$-0.2060.00%
05/10/2007---$-1-33.33%
03/15/2007---$-2.10-68.00%
11/03/2006---$-1.20-14.29%
08/08/2006---$-0.9043.75%
05/08/2006---$-1.70-30.77%
03/02/2006---$-2.70-28.57%
11/03/2005---$-2.90-38.10%
08/08/2005---$-1.905.00%
05/10/2005---$-1.30-8.33%
03/16/2005---$-1.41---
11/08/2004---$-2-42.86%
07/28/2004---$-2.3025.81%
05/05/2004---$-1.20-20.00%
02/11/2004---$-0.6025.00%
11/05/2003---$-0.64---
07/31/2003---$-0.98---
05/05/2003---$-0.67---
02/04/2003---$-5.59---
10/30/2002---$-1.42---
07/29/2002---$-2.15---
05/03/2002---$-1.85---
01/30/2002---$-30.00%
11/01/2001---$-2.5014.68%
08/02/2001---$-2.7016.92%
03/31/2001---$-3.08---
02/01/2001---$-2.6041.57%
09/30/2000---$-1.90---
06/30/2000---$-47.74---

More About Insmed Inc

Website
https://www.insmed.com
Country
USA
Full Time Employees
1,271

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also devlops brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1(DPP1) that is in phase 3 clinical trial for the treatment of bronchiectasis; and in phase 2 clinical trial for the treatment of chronic rhinosinusitis without nasal polyps and hidradenitis suppurativa. In addition, the company is developing treprostinil palmitil inhalation powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil, which is in phase 3 clinical trial for the treatment of pulmonary hypertension associated with interstitial lung disease; and phase 2 clinical trial for the treatment of pulmonary arterial hypertension. Further, it develops gene therapy, a microdystrophin adeno-associated virus gene replacement therapy which is in phase 1 clinical trial for the treatment of Duchenne muscular dystrophy, as well as is in pre-clinical development for gene therapy, next generation DPP1 inhibitor, deimmunized therapeutic protein, and synthetic rescue. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

“Insmed Inc Earnings” Can Refer to the Insmed Inc Earnings Date

Some people say “Insmed Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Insmed Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Insmed Inc Stock on the Earnings Date

If you own Insmed Inc stock (INSM) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Insmed Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Insmed Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Insmed Inc Earnings

You can contact us any time if you would like to ask questions about Insmed Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.